Part of that reflects intensifying competition from Eli Lilly, which now commands 58% of total U.S
A previous study on GLP-1R activation in several species reported approximately 50% and 30% potency of liraglutide at the mouse and rat receptors, respectively [54]
However, a retrospective cohort study of electronic health records involving 240,618 patients with overweight or obesity prescribed semaglutide or non-GLP-1 receptor agonist antiobesity medications, and 1,589,855 patients with type 2 diabetes prescribed semaglutide or other hypoglycaemic agents, found a lower risk of suicidal ideation in patients prescribed semaglutide regardless of prior psychiatric history
However, both resources should be applied with extra caution when one component is a potent triple agonist like retatrutide
Consider DEXA scans for baseline and follow-up in those with osteopenia or osteoporosis
its designed to extend it. The need is especially urgent as more patients consider what comes after GLP-1 treatment